Selected Publications

Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun: Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL Leukemia & Lymphoma 64 (14): 2023.

Bryer E, Itsara A, Ahn I et al.: Ibrutinib-associated sudden death in patients with CLL Blood 140 (Supplement 1): 2022.

Bryer EJ, Destefano C, Kazandjian D.: Current and prospective antibody-based therapies in multiple myeloma Semin Oncol 49 (1): 41-47,2022.

Bryer EJ, Stein E, Goldberg S.: Multivessel Coronary Artery Disease Mayo Clinic Proceedings: Innovations, Quality, and Outcomes. : 2020.

Bryer E, Dew A, Hill E, et al.: A phase II pilot study of avelumab in combination with hypofractionated radiotherapy in patients with relapsed refractory multiple myeloma Blood 136 (Supplement 1): 2020.

Bryer EJ, Kallan MJ, Chiu TS.: A Retrospective Analysis of Venous Thromboembolism Trends in Chemotherapy- Induced Anemia: Red Blood Cell Transfusion Versus Erythrocyte Stimulating Agent Administration. EJHaem 1 (1): 35-43,2020.

Bryer EJ, Manno M, Kinniry P, Hartner L.: Primary Pulmonary Histiocytic Sarcoma Presenting with Hemoptysis. Cancer Science and Research. 2 (1): 1-5,2019.

Bryer EJ, Asturias K, Kinniry P.: Acute Severe Refractory Immune Thrombocytopenic Purpura in the Setting of Uncontrolled Systemic Lupus Erythematosus. Haematology International Journal. 3 (2): 1-6,2019.

Bryer EJ, Neault M, Mintzer D.: Managing Dying: Medical Care and Decision Making at the Very End of Life. Palliative Medicine and Care. 6 (1): 1-6,2019.

Bryer EJ, Henry DH.: Gestational Ovarian Choriocarcinoma: A Review of the Literature and Presentation of a Perplexing Case. International Journal of Clinical Oncology and Cancer Research. 3 (6): 72-77,2019.

Academic Contact Information

230 W Washington Square
Philadelphia, PA 19106
Patient appointments: 800-789-7366